Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Both mouse and rat models are effective for testing alopecia areata treatments.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Tooth regeneration could become possible by controlling how and when bioactive factors are released.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.